Gen.Orph Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • 2ndary - Private

Gen.Orph General Information

Description

Developer of generic orphan drugs designed to treat rare diseases in children. The company's drugs offer patients and medical teams worldwide generic orphan medicines that are affordable and effective at curing rare diseases as well as drugs that are neglected by the pharmaceutical industry despite their medical efficiency, enabling patients to get treatment for rare diseases at affordable costs.

Contact Information

Website
www.gen-orph.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 1 rue royale
  • Saint-Cloud
  • 92210 Paris
  • France
+33 01
Primary Industry
Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • 1 rue royale
  • Saint-Cloud
  • 92210 Paris
  • France
+33 01

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gen.Orph Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Oct-2021 Completed Generating Revenue
3. Later Stage VC 01-Apr-2020 Completed Generating Revenue
2. Later Stage VC 16-Feb-2017 $642K $2.7M Completed Generating Revenue
1. Early Stage VC 01-Jan-2014 $2.06M $2.06M Completed Generating Revenue
To view Gen.Orph’s complete valuation and funding history, request access »

Gen.Orph Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Class C
Class C
To view Gen.Orph’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Gen.Orph Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Gen.Orph FAQs

  • When was Gen.Orph founded?

    Gen.Orph was founded in 2012.

  • Where is Gen.Orph headquartered?

    Gen.Orph is headquartered in Paris, France.

  • What is the size of Gen.Orph?

    Gen.Orph has 12 total employees.

  • What industry is Gen.Orph in?

    Gen.Orph’s primary industry is Pharmaceuticals.

  • Is Gen.Orph a private or public company?

    Gen.Orph is a Private company.

  • What is Gen.Orph’s current revenue?

    The current revenue for Gen.Orph is .

  • How much funding has Gen.Orph raised over time?

    Gen.Orph has raised $3.72M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »